Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson Prepares to Test IPO Waters
08:16pm, Sunday, 23'rd Apr 2023
Johnson & Johnson is reportedly readying an investors roadshow to take its commercial healthcare unit public. According to a Sunday (April 23) Wall Street Journal (WSJ) report, sources familiar with t
J&J Consumer-Health IPO Process to Kick Off Key Test for Moribund New-Issue Market
05:43pm, Sunday, 23'rd Apr 2023
Kenvue plans to start meeting with prospective investors as early as Monday.
If You're a Dividend Investor, You'll Love This News From Johnson & Johnson
02:00pm, Saturday, 22'nd Apr 2023
J&J has proved that paying out dividends is important to the company. The big pharma player paid out $2.9 billion to shareholders in the first quarter.
Some of the Top Healthcare Companies Reside in this ETF
10:46am, Saturday, 22'nd Apr 2023
While still sporting a modest year-to-date loss, the S&P 500 Health Care Index is higher by 4.44% over the past month, and with the healthcare sector's reputation for defensive and quality traits, it
3 Top Dividend Kings to Buy for the Long Haul
07:20am, Saturday, 22'nd Apr 2023
Johnson & Johnson just raised its quarterly dividend for the 61st straight year. AbbVie is counting on Skyrizi and Rinvoq and its deep pipeline to help replace lost revenue from Humira.
3 Best Dividend Kings For The Rest Of 2023
09:05am, Friday, 21'st Apr 2023
3 Best Dividend Kings For The Rest Of 2023.
J&J says US judge temporarily halts most of the lawsuits alleging it's talc products caused cancer
03:38am, Friday, 21'st Apr 2023
Johnson & Johnson (NYSE:JNJ) said a US judge has temporarily halted most of the tens of thousands of lawsuits alleging the company's talc products, including baby powder, caused cancer, Reuters has r
U.S. bankruptcy judge halts 40,000 talc-cancer lawsuits against Johnson & Johnson
05:30pm, Thursday, 20'th Apr 2023
Judge Michael Kaplan's decision is part of J&J's second attempt to settle tens of thousands of talc-cancer cases in bankruptcy proceedings.
Johnson & Johnson (JNJ) Could Be a Great Choice
12:57pm, Thursday, 20'th Apr 2023
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
DIVB: Shareholder Yield Is A Good Idea, But Cambria Did It Better
10:56am, Thursday, 20'th Apr 2023
DIVB: Shareholder Yield Is A Good Idea, But Cambria Did It Better.
Where is the current bull market? All indications would be that it's in biotech!
Johnson & Johnson Earnings Mix Some Good with Some Concerns
07:04am, Thursday, 20'th Apr 2023
Despite beating on the top and bottom lines in its first quarter earnings report, shares of Johnson & Johnson (NYSE: JNJ) are down about 1% for the week. Some of this is because the market itself is d
Johnson & Johnson: U.S. Health Trends A Key Catalyst For Growth
12:11am, Thursday, 20'th Apr 2023
Johnson & Johnson: U.S. Health Trends A Key Catalyst For Growth.
ETFs to Buy on Solid Q1 JNJ Earnings Results
12:56pm, Wednesday, 19'th Apr 2023
Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.
2 Top Dividend Stocks You Can Buy and Hold Forever
08:30am, Wednesday, 19'th Apr 2023
Microsoft and Johnson & Johnson have two of the highest credit ratings in the world. The companies also generate lots of cash.
